Chariyavilaskul P, Prompila N, Wittayalertpanya S, Lekhyananda S, Prasithsirikul W, Trakarnvanich T
Clin Transl Sci. 2024; 17(7):e13884.
PMID: 39004798
PMC: 11246974.
DOI: 10.1111/cts.13884.
Osegueda A, Polo M, Baquero L, Urioste A, Ghiglione Y, Paz S
Open Forum Infect Dis. 2023; 10(12):ofad591.
PMID: 38107019
PMC: 10723816.
DOI: 10.1093/ofid/ofad591.
Benhammou J, Leng M, Shah S, Cholankeril G, Dong T, Patel A
JAMA Netw Open. 2023; 6(12):e2346380.
PMID: 38048128
PMC: 10696483.
DOI: 10.1001/jamanetworkopen.2023.46380.
Hofmeister M, Zhong Y, Moorman A, Samuel C, Teshale E, Spradling P
Clin Infect Dis. 2023; 77(12):1668-1675.
PMID: 37463305
PMC: 11017377.
DOI: 10.1093/cid/ciad425.
Rogers K, Halvorson T, Krasowski M, Merrill A
J Clin Lab Anal. 2023; 37(7):e24887.
PMID: 37106580
PMC: 10220299.
DOI: 10.1002/jcla.24887.
Repurposing of drug molecules from FDA database against Hepatitis C virus E2 protein using ensemble docking approach.
Chaudhuri D, Datta J, Majumder S, Giri K
Mol Divers. 2023; 28(3):1175-1188.
PMID: 37061608
DOI: 10.1007/s11030-023-10646-2.
Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
Skinner N, Ogega C, Frumento N, Clark K, Yegnasubramanian S, Schuebel K
Front Immunol. 2023; 14:1135841.
PMID: 37033983
PMC: 10080129.
DOI: 10.3389/fimmu.2023.1135841.
Challenges Facing Viral Hepatitis C Elimination in Lebanon.
Ayoub N, Hatab T, Bizri A
Pathogens. 2023; 12(3).
PMID: 36986354
PMC: 10057017.
DOI: 10.3390/pathogens12030432.
Epidemiological and Clinical Factors Associated with Spontaneous Clearance of Hepatitis C Virus.
Guenifi W, Gasmi A, Lacheheb A
Middle East J Dig Dis. 2023; 13(4):321-327.
PMID: 36606021
PMC: 9489441.
DOI: 10.34172/mejdd.2021.241.
HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates.
Lens S, Miralpeix A, Galvez M, Martro E, Gonzalez N, Rodriguez-Tajes S
JHEP Rep. 2022; 4(12):100580.
PMID: 36316992
PMC: 9617206.
DOI: 10.1016/j.jhepr.2022.100580.
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.
Korenaga M, Murata K, Izumi N, Tamaki N, Yokosuka O, Takehara T
Glob Health Med. 2022; 4(4):216-224.
PMID: 36119787
PMC: 9420328.
DOI: 10.35772/ghm.2022.01026.
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts.
Feld J, Forns X, Dylla D, Kumada H, de Ledinghen V, Wei L
J Viral Hepat. 2022; 29(12):1050-1061.
PMID: 36036117
PMC: 9827821.
DOI: 10.1111/jvh.13738.
Forced Degradation Studies and Development and Validation of HPLC-UV Method for the Analysis of Velpatasvir Copovidone Solid Dispersion.
Zaman B, Hassan W, Khan A, Mushtaq A, Ali N, Bilal M
Antibiotics (Basel). 2022; 11(7).
PMID: 35884151
PMC: 9311562.
DOI: 10.3390/antibiotics11070897.
Chemokine receptor CXCR6 gene polymorphism and treatment response of chronic hepatitis C virus in Egyptian patients.
Hassona M, Fouad T, Helmi M, Ghanem H, Elrhman H, Abdelsameea E
Clin Exp Hepatol. 2022; 7(4):370-376.
PMID: 35402715
PMC: 8977876.
DOI: 10.5114/ceh.2021.111490.
Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.
Bressler S, Bruden D, Nolen L, Bruce M, Towshend-Bulson L, Spradling P
Can J Gastroenterol Hepatol. 2022; 2022():2573545.
PMID: 35178364
PMC: 8847038.
DOI: 10.1155/2022/2573545.
HCV Infection Alters Salivary Gland Histology and Saliva Composition.
Maldonado J, Beach M, Wang Y, Perez P, Yin H, Pelayo E
J Dent Res. 2022; 101(5):534-541.
PMID: 35045743
PMC: 9052835.
DOI: 10.1177/00220345211049395.
Hepatitis C Virus Screening: Factors Associated With Test Completion in a Large Academic Health Care System.
Kasting M, Christy S, Reich R, Rathwell J, Roetzheim R, Vadaparampil S
Public Health Rep. 2021; 137(6):1136-1145.
PMID: 34694928
PMC: 9574314.
DOI: 10.1177/00333549211054085.
Nonadherence to Ledipasvir/Sofosbuvir Did Not Predict Sustained Virologic Response in a Randomized Controlled Trial of Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Persons Who Use Drugs.
Ward K, Falade-Nwulia O, Moon J, Sutcliffe C, Brinkley S, Haselhuhn T
J Infect Dis. 2021; 225(5):903-911.
PMID: 34543417
PMC: 8889293.
DOI: 10.1093/infdis/jiab477.
Sexually Transmitted Infections Treatment Guidelines, 2021.
Workowski K, Bachmann L, Chan P, Johnston C, Muzny C, Park I
MMWR Recomm Rep. 2021; 70(4):1-187.
PMID: 34292926
PMC: 8344968.
DOI: 10.15585/mmwr.rr7004a1.
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use.
Fuster D, Garcia-Calvo X, Zuluaga P, Bolao F, Muga R
World J Gastroenterol. 2021; 27(23):3223-3237.
PMID: 34163107
PMC: 8218351.
DOI: 10.3748/wjg.v27.i23.3223.